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one aspect of serendipity to bear in mind is that you have to be looking 
for something in order to find something else.
       
Lawrence Block

abstract
Proinsulin C-peptide is depleted together with insulin in type I diabetic 
patients. The supplement of insulin to these patients is necessary for their 
survival, but it is also likely that the loss of C-peptide may contribute to both 
short- and long-term complications. In this thesis, molecular effects of C-pep-
tide have been investigated. In particular, nuclear effects of C-peptide and 
C-peptide involved in oligomerization have been studied, as well as method 
development to facilitate further protein interaction analysis.
C-peptide is a small peptide hormone with known membrane-binding proper-
ties that is thought to stimulate G-protein coupled receptor associated pathways. 
In this thesis we report that C-peptide not only acts extracellularly, but that it is 
internalized via specific mechanims and interacts with cytoskeletal proteins. 
We show that C-peptide is transferred to the nucleus, and specifically to the 
rRNA-synthesizing organelle nucleolus where it stimulates transcription of rDNA. 
Transcription of rDNA is related to a complex of proteins at the promoter region 
including histone 4 that gets acetylated upon interaction with C-peptide. We fur-
ther link this transcriptional activity of C-peptide to proliferation in a model system 
relevant to the bone growth retardation observed in type I diabetic patients suf-
fering from fractures. To understand more of C-peptide’s effects on the basis of 
the transcriptional activity observed, a genome analysis of proximal tubular cells 
isolated from type I diabetic rats was performed. It revealed that C-peptide within 
2 hrs exerts tight effects on transcription with ~500 genes affected and the major-
ity of them being repressed. This observation suggests that C-peptide treatment 
corrects malfunctioning pathways, especially pathways of circulatory and inflam-
matory diseases.We have also studied oligomerization of C-peptide, and find 
that C-peptide oligomers are disrupted by insulin in addition to a previous study 
reporting that C-peptide disrupts insulin hexamers. The C-peptide oligomers are 
formed via electrostatic interactions, and can further lead to aggregates with a 
high content of ß-sheets.
In summary, this thesis provides data on C-peptide being an intracrine 
hormone with intracellular effects in addition to having extracellular activity via 
classical endocrinological pathways. We also discuss the implications of the 
C-peptide oligomers we observe, which provide evidence that C-peptide may 
act as an insulin chaperone. It is evident that a fine-balanced homestasis of 
C-peptide is necessary for optimal health in both type I and II diabetic patients.
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lIst of abbrevIatIons
One letter codes for the 20 naturally occuring amino acids.
A  Alanine 
R  Arginine 
N  Asparagine 
D  Aspartic acid 
C  Cysteine 
E  Glutamic acid
Q  Glutamine 
G  Glycine 
H  Histidine 
I  Isoleucine 
L  Leucine
K  Lysine 
M  Methionine
F  Phenylalanine 
P  Proline
S  Serine 
T  Threonine
W  Tryptophan 
Y  Tyrosine 
V  Valine
acH4K16 Acetylated histone 4 lysine 16
APPL Adaptor protein containing PH domain, PTB domain and   
 leucine zipper motif
ATF Activating transcription factor
ATR Attenuated total reflection
bFGF Basic fibroblast growth factor
CaMK Calcium/calmodulin-dependent kinase
cAMP Cyclic adenosine monophosphate
CASK Calcium/calmodulin-dependent serine protein kinase
CD Circular dichroism
ChIP Chromatin immunoprecipitation
Cp C-peptide
CREB cAMP response element-binding
DLS Dynamic light scattering
EGF Epidermal growth factor 
eNOS Endothelial nitric oxide synthase
ER Endoplasmatic reticulum
ERK Extracellular signal-regulated kinase
FACS Fluorescence-activated cell sorting
Ft Fourier transform
GGH Glycine glycine histidine
GPCR G-protein coupled receptor
I Insulin
IP Immunoprecipitation
IR Infrared
Kd Dissociation constant
LC Liquid chromatography
MS Mass spectrometry
NMR Nuclear magnetic resonance
NF-κB Nuclear factor κB
PAGE Polyacrylamide gel electrophoresis
PCR Polymerase chain reaction
pI Isoelectric point
PI Proinsulin
PKC Protein kinase C
PP2B Protein phosphatase 2B
PPI Preproinsulin
PTHrP Parathyroid hormone-related protein
PTP1B Protein tyrosine phosphatase 1B
PTX Pertussis toxin
PVDF Polyvinylidene fluoride 
qPCR real-time quantitative PCR
Rh Rhodamine
SDS Sodium dodecyl sulfate
STAT3 Signal transducer and activator of transcription 3
TFE Trifluroethanol
VACM-1 Vasopressin-activated Ca2+-mobilizing receptor
lIst of fIgures 
Figure 1. Biosynthesis of C-peptide.
Figure 2. Amino acid sequence of C-peptide.
Figure 3. Hormone signaling pathways.
Figure 4. Crosslabeling workflow.
Figure 5. Three-site activity model of C-peptide.
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IntroductIon
a personal reflectIon
My first real contact with peptides was with cell-penetrating ones at Stock-
holm University. Then, my second was, as I arrived to the Department of 
Medical Biochemistry and Biophysics at Karolinska Institutet, antimicrobial 
peptides. They too, penetrate cell membranes. Thus, I was strongly biased 
to believe that other peptides always behave in this penetrative way. I still 
remember writing one of my first emails to my professor, suggesting that we 
should look at C-peptide, if it did so too. I got an encouraging reply that it 
was good to be curious and think wide. Eventually a combination of ideas, 
methodology, previous observations and collaboration got us on our quest, 
and we went into the midpoint of the cell. That quest continued us on the 
way of C-peptide oligomers, as our need of looking at Western blots of intra-
cellular C-peptide made us observe the funny bands it occupied. But that’s 
going too far ahead, too early.
To me, research about C-peptide has been like A journey to the centre of 
the earth and Around the world in eighty days – traveling through different 
spaces, finding adventure and fun. It has never been straightforward, or 
plain, instead this very small molecule has continued to elude us, showing 
new facettes, demanding of us creative skills and thinking. The C-peptide 
has sure made me a believer in the complexity of nature, its variability, and 
proneness to evolution.
This thesis is devoted to studies of C-peptide, its function, properties and 
ultimately, behaviour. I am fortunate to have been on this endevour with such 
open-minded and creative people.
 thinking is more interesting than knowing, but less 
 interesting than looking.
 
 Goethe
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background
c-peptIde orIgIn 
C-peptide was first described by Steiner et al. in 1967 (1, 2) in their work on 
the biosynthesis of insulin. The precursor proinsulin was proposed to exist to 
either protect insulin during intracellular transport or to aid in the assembly 
of the native insulin molecule. The latter was quickly found to be true, as C-
peptide is vital for the proper formation of insulin disulphide bonds and hence 
the folding of insulin (3). It was later evidenced that even a precursor of pro-
insulin itself existed, a very short-lived preproinsulin molecule degraded prior 
to completion of preproinsulin synthesis (4, 5).
 
Figure 1. Biosynthesis of C-peptide. To the left, a view of the cellular local-
ization of biosynthesis is shown, and to the right, a scheme of the biosynthe-
sis. Endoplasmatic reticulum (ER), preproinsulin (PPI), proinsulin (PI), insulin 
(I) and C-peptide (Cp). 
C-peptide is predominatly synthesized by ß-cells in the islets of Langerhans 
in the vertebrate pancreas, but evidence also exists of preproinsulin in the 
eye (6) and other parts of the brain (7), and in the gut (8). As shown in Figure 
ER
Golgi
PPI
PI
I+CpCell 
membrane
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1, the precursor preproinsulin is directed to the endoplasmatic reticulum 
(ER) via its signal peptide that thereupon is cleaved off. Moving through the 
ER and the Golgi apparatus, the resulting proinsulin molecule is packed into 
secretory granules in which peptidases cleave proinsulin into insulin and 
C-peptide. These two peptides are then released into the blood stream in 
equimolar amounts upon stimuli.
C-peptide early provened to be valuable in clinical investigations of type 
I diabetes. Insulin is quickly depleted from the blood, and as C-peptide 
circulates for a longer time, it was recognized to be useful in immunoas-
saying residual insulin levels (9, 10). The following decade, most work on 
C-peptide focused on its role as a tool in the study of pancreatic disorders 
relying on its detectability in immunoassays. Also, basic investigations of its 
biological properties, including half-life (30 min) (11), major breakdown organ 
(kidney) (12) and sequence variability between species, were conducted. It 
was argued by some that C-peptide must lack any intrinsic biological func-
tion due to its sequence variability between species, although Kitabchi stated 
already in 1977 that ”the distribution of acidic, polar, and nonpolar amino 
acid residues along the C-peptide in proinsulin is similar from species to spe-
cies” (13). The few investigations of C-peptide biological function that were 
carried out aimed primarily at finding insulin-like activity in insulin-sensitive 
tissues, and as no such effects were observed, C-peptide was generally held 
as a facilitator of insulin folding useful in tracing residual insulin secretion in 
diabetic patients. 
c-peptIde effects
physiological responses to c-peptide
No story of C-peptide can be held separate from that of insulin, reported by 
Banting and Best in 1922 (14). Insulin was an enormous medical finding, 
saving thousands of lives annually, and the discovery of C-peptide was most 
probably associated with an anticipation of further understanding of type I 
diabetes. As Steiner et al. argue, the discovery of an insulin precursor could 
explain why type I diabetic patients have normal and even elevated levels of 
insulin at the disease onset, but it could also be a no-function vestige of an 
evolutionary ancestor (1). Further studies of C-peptide itself, aimed at finding 
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an activity similar to that of insulin, led C-peptide to be attached to its epithet 
“inactive byproduct” albeit several studies showed the opposite (15).
Studies of C-peptide effects on insulin secretion revealed that this co-
secreted connecting peptide exerted negative effects on insulin release, sug-
gesting a classical negative feedback inhibition mechanism (16, 17). Specific 
binding of C-peptide to insulin-secreting ß-cells was observed a few years 
later (18). Furthermore, hypoglycaemic activity of C-peptide (17) and stimu-
latory effects on glucose transport and glycogen synthesis were reported 
(19). The stimulatory effect on glucose utilization was observed also in type I 
diabetic patients together with a finding of C-peptide alleviating renal dys-
function (20). The involvement of C-peptide in glucose utilization and insulin 
activity came to dominate the following years apart from a study describing 
the C-peptide of a Locusta insulin-like peptide to have electrophysiological 
activity (21), acting on ion channel opening. 
It is not inconceivable that the abundance of reports implicating C-peptide 
involvement in insulin activity and glucose utilization separate to that of the 
insulin receptor (22) led researchers to observe that diabetic patients with re-
sidual ß-cell function have improved blood glucose control, and even more, 
less suffering of retinopathy and microvascular lesions (23, 24). A continuos 
work on the benefits of C-peptide for type I diabetic patients, as summarized 
by Wahren et al. (25), ultimately discharged into research on the underlying 
protective molecular mechanisms of C-peptide.
cellular effects 
The inhibitory effect of C-peptide on insulin secretion and the binding to ß-
cell membranes constitute two of the first observed cellular effects (16, 18). 
Specific binding to several human cell membranes was later observed and 
concluded to occur via a G-protein coupled receptor (GPCR) (26). As much 
effort focused on explaining observed physiological effects in the kidney, 
on glucose homeostasis and microcirculation, the abundant, ion channel 
Na+K+ATPase was investigated regarding its potential response to C-peptide. 
The ion channel was known to be targeted by many peptide hormones, and 
indeed C-peptide was shown to do so as well, possibly via calcium-activated 
protein phosphatase 2B (PP2B) and protein kinase C (PKC) (27, 28). 
C-peptide was also shown to increase calcium influx (29). All of these effects 
were inhibited by treatment with pertussis toxin, which is why a GPCR long 
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has been quested as a partner for C-peptide. 
C-peptide has also been shown to have stimulatory effects on endothelial 
nitric oxide synthase (eNOS), connected to the beneficial effect of C-peptide 
on microcirculation (30). The effect on eNOS is mediated via extracellular 
signal-regulated kinase (ERK) pathway activation (31), hence also related to 
a GPCR activity. 
Interactions of c-peptide
In the context of cellular activity, C-peptide has been shown to have specific 
binding to the cell membranes of ß-cells (18), renal tubular cells (26) and 
fibroblast cells (32). Rigler et al. showed the interaction to have a dissocia-
tion constant corresponding to a receptor binding, but they also showed a 
smaller fraction of nonspecific bindning (32). As no receptor has been identi-
fied, no detailed mechanism concerning the interaction recipient is known. 
Nonetheless, this receptor has been assumed to be a GPCR as several 
studies has shown that cellular effects of C-peptide are compromised by 
pertussis toxin (PTX) treatment (27, 29). However, PTX has been shown not 
to be as specific as presumed, and can instead be held as a disruptive agent 
of several cellular processes (33). Another study showed that a reverse se-
quence version of C-peptide and an enantiomer (D)-C-peptide version elic-
ited the same biological activity as C-peptide, suggesting that the effect was 
not mediated via a receptor (34) but instead via non-chiral interactions. It 
was later shown that C-peptide can induce formation of cation (K+)-selective 
channels in lipid bilayers (35), although other studies have shown no interac-
tion between C-peptide and neutral or anionic vesicles and micelles (36). 
Studies have shown that certain activities of C-peptide are connected to its 
metal-binding properties (37, 38), to zinc in particular. Zinc is an ion bioavail-
able to C-peptide in relevant amounts. In relevance to C-peptide’s disaggre-
gation of insulin hexamers (39), zinc can be released upon the disaggrega-
tion as the hexamers each contain two zinc atoms (40).
properties of c-peptide  
Human C-peptide consists of 31 amino acid residues as shown in Figure 2, 
has a molecular weight of 3020 Da, and an isoelectric point (pI) of 3. The 
peptide exhibits a large sequence variation between species, with glutamic 
residues 3 and 27 being the only residues highly conserved (41).However, 
17
the N- and C-terminal portions of C-peptide, as well as the middle glycine-
rich stretch are also relatively well conserved (41, 42), and as mentioned 
earlier, the distribution of certain groups of amino acids is similar (13).
Figure 2. Amino acid sequence of C-peptide. Full and partial charges are 
shown as indicated. Amino acids are abbreviated as given in the List of ab-
breviations.
C-peptide has been shown to have no ordered secondary structure as exam-
ined by circular dichroism (CD) spectroscopy, although trifluroethanol (TFE) 
can induce an a-helical structure in the N-terminal portion of C-peptide (36). 
This has been further supported by an extensive nuclear magnetic reso-
nance (NMR) study, showing that the N- and C-terminal parts of C-peptide 
can adopt ordered structures (42). 
IntracrIne factors
Chemical signaling has long been classified as endocrine, paracrine, juxta-
crine and autocrine. In recent years, Re and colleagues have introduced the 
term intracrine which allows for an additional classification (43, 44), Figure 
3. An intracrine peptide in their words describes a traditional endo-, para- or 
autocrine hormone that additionally is associated with an intracellular organ-
elle not belonging to the secretory or degradatory pathway, ideally exert-
ing a biological action on the basis of this association. This provides a new 
intracellular arena for understanding peptide hormones’ and other signaling 
molecules’ mode of communication. Previously, much signaling has been be-
lieved to occur via receptor binding.
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Figure 3. Hormone signaling pathways. Classical endo-(E), para-(P), auto-
(A) and juxtacrine(J) pathways (green) and intracrine(I) (pink).
Intracrines share functional features; regulation of growth, effects on angio-
genesis and interactions with the nucleus and nucleolus (45). It also seems 
as if intracrines modify the corresponding extracellular actions. Intracrine 
parathyroid hormone-related protein (PTHrP) has been shown to increase 
cell survival and growth, whereas extracellular PTHrP reduces both (46).
Endo-, para-, auto- 
and juxtacrine
Intracrine
E
P
A
J
I
II
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aIms of thIs thesIs
The overall aim of this thesis has been to understand cellular mechanisms 
by which C-peptide exerts its effects, and if possible, relate those findings to 
physiological responses of C-peptide. 
More specifically, the work has been aimed at
 
  • analysis of C-peptide interactions with the cell surface
 • investigation of methods useful for protein interaction analysis
 • investigation of C-peptide properties.
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methodology 
Experimental procedures in papers I-vI are described below. Material and 
methods used in each study are described in papers I-vI.
bIochemIcal methods
enzymatic activity assay
For assay of protein tyrosine phosphatase (PTP) 1B activity in the presence 
of C-peptide and C-peptide fragments (paper Iv), the enzyme and each 
peptide were preincubated to allow for binding to occur prior to addition of 
high-affinity and concentrated substrate. Activity of PTP-1B was determined 
by endpoint analysis.
gel analysis
In this thesis, both polyacrylamide gel electrophoresis (PAGE) and aga-
rose gel analysis have been performed (papers II, Iv and vI, and paper II, 
respectively). PAGE has been used in both denaturing (papers II and Iv-vI) 
and native (papers v and vI) conditions. 
PAGE analysis
PAGE analysis is used to separate peptides and proteins according to 
charge and size (47). The analytical mixture is applied to a polymeric mesh 
of acrylamide, and separation is achieved based on the permeability of pep-
tides and proteins as they are drawn through the mesh by an electrical field. 
With sodium dodecyl sulfate (SDS) PAGE, proteins are denatured and given 
a net negative charge by SDS, upon which they migrate based on size in an 
electrical field. In native PAGE, the undenatured proteins move according 
to their intrinsic charge and mass, and complexes and aggregates can be 
observed.
Agarose gel analysis
Agarose gel analysis is predominantly used for separation of nucleic acids, 
as it has a larger separation range than polyacrylamide.
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c-peptide detection
Following PAGE, separated analytes can be visualized by staining methods 
(Coomassie and silver staining) or Western blot analysis. Coomassie and 
silver stains are widely used methods that rely on the analyzed peptide(s) or 
protein(s) to contain the functional groups required for staining. Silver stains 
interact predominaly with carboxylic acid, imidazole, sulfhydryl and amine 
groups (48). C-peptide, containing many carboxylic acid groups, should be 
expected to stain with silver. However, C-peptide only stains with Silver Stain 
Kit (Pierce), and only in very high amounts (>5mg). Coomassie dye stains 
with a chemistry primarily directed at lysine, histidine and arginine residues 
(49) – of which C-peptide contains none. Hence, C-peptide staining poses a 
problem. A C-peptide conjugate with rhodamine (Rh) can be used to directly 
visualize C-peptide in a gel (paper v). 
Western blot allows for an alternative visualization as it is based on high 
affinity epitope recognigition by an antibody. There are several monoclonal 
antibodies for C-peptide that work well for immunofluorescence (paper I). 
Western blot analysis requires the analytes to adhere to either a polyvi-
nylidene fluoride (PVDF) or a nitrocellulose surface. The adherence to a 
PVDF surface is based upon hydrophobic interactions, and to a nitrocel-
lulose surface on a combination of hydrophobic and electrostatic interac-
tions. C-peptide only in certain settings adheres to nitrocellulose membranes 
(paper v), and virtually never to a PVDF membrane. The use of biotinylated 
C-peptide circumvents the problem as a streptavidin-conjugate can then be 
used to visualize C-peptide, the biotin rendering better detection sensitivity 
and adherence properties (papers v and vI). 
mass spectrometry
Mass spectrometry (MS) has been used as described in papers I, II, Iv 
and v. Tryptic digests have been analyzed by liquid chromatography (LC) 
tandem MS (MS/MS) (50) to identify C-peptide interacting proteins (papers I 
and II) and to establish an MS-compatible workflow (paper Iv). In paper v, 
MS was used to analyze peptide interactions.
protein interaction analysis
The interactions of C-peptide with other proteins and peptides have been 
studied in papers I, II, Iv and vI. Techniques employed include the Biacore 
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technology, pull-down interaction analysis or affinity precipitation, co-immu-
noprecipitation, crosslabeling, native PAGE and MS. They are methodologi-
cally described in the separate publications. 
C-peptide’s negative charge (pI~3), small size (3 kDa) and lack of amino 
groups apart from its N-terminal one, pose problems when studying C-pep-
tide interactions, as briefly discussed below.
One commonly used technique to capture interactions is immunoprecipita-
tion (IP), used in paper II to capture histone 4 (chromatin IP (ChIP) analysis). 
This technique cannot be employed with C-peptide due to its small size, as 
it can become inaccessible to its antibody when interacting with proteins 
(compare cytosolic versus nuclear immunofluorescence intensity in paper I). 
To circumvent this problem we have used an N-terminally linked biotin-C-pep-
tide. Biotin-streptavidin have a dissociation constant (Kd) in the order of ~10-15 
mol/L, which makes it one of the strongest non-covalent interactions known. 
This phenomenon is utilized in the Dynabeads technology (Invitrogen) that 
allows for pull-down of biotinylated species by beads coated with streptavidin. 
Due to the previously mentioned properties of C-peptide, the biotin-C-peptide 
is first non-covalently attached to streptavidin beads, and then allowed to 
interact with an analytical mixture (papers II and Iv). Biotin-C-peptide has 
also been used in Biacore experiments immobilizing C-peptide to streptavidin 
chips, as C-peptide due to its negative charge cannot be chemically attached 
to the commonly used Biacore carboxyl surface (paper I).
Crosslinking and crosslabeling are well used techniques as they allow for 
in vivo capture of protein interactions, as well as enrichment. Paraformalde-
hyde can be used to crosslink protein-protein and protein-DNA interactions 
with subsequent enrichment of interacting partners either via affinity tags 
or epitope recognition (as in ChIP analysis, paper II). Reactive groups can 
also be covalently attached to a bait, i.e. C-peptide, and then be activated to 
crosslink with interacting partners. However, this covalent attachment mostly 
relies on sulphydryl and amino group chemistry, and C-peptide contains only 
one amino group. Secondly, the bioconjugates are often of considerable size 
in relation to C-peptide.
A crosslabeling technique suitable to C-peptide’s special prerequisites was 
adapted, described below (paper Iv).
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Crosslabeling
Brown et al. (51, 52) have described a crosslabeling method based on oxida-
tion-mediated biotinylation of interacting species. A glycine-glycine-histidine 
(GGH) motif is introduced at the N-terminus, acting as a small histidine tag 
with high affinity for nickel. The nickel is oxidized and activates a biotin-
conjugate that reacts within a defined space of the GGH-C-peptide, thereby 
biotinylating interacting species, Figure 4.
One important feature of this method is the sequestering of nickel. The 
GGH-tag only binds nickel above pH 6, and as C-peptide is acidic enough to 
significantly lower the pH of a solution, an ammonium acetate solution of pH 
8.5 was used for nickel binding prior to crosslabeling. The use of ammonium 
actetate also facilitated the introduction of an MS-compatible step to allow 
for a workflow resulting in identification (paper Iv). Following crosslabeling, 
biotinylated targets are enriched with the previously described Dynabeads 
technology, and either subjected to in-solution or in-gel tryptic digestion. 
Digests are then analyzed by liquid chromatography tandem mass spectrom-
etry (LC-MS/MS).
Figure 4. Crosslabeling workflow. Incubation of bait peptide tagged with 
GGH:Ni and protein mixture with oxidative reagents mediates labeling of 
interacting species. Interaction partners are isolated and analyzed by mass 
spectrometry (LC-MS/MS).
GGH:Ni
Protein mixture
Biotin-tyramine
Oxidative 
crosslabeling Capture
Trypsination
LC-MS/MS
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bIophysIcal methods
circular dichroism spectroscopy
CD analysis is used to analyze optically active molecules, including chro-
mophoric proteins and peptides (53). How the chiral light interacts with a 
chiral sample, i.e.a peptide, gives information of the secondary structure. We 
used CD analysis in paper vI to monitor structure changes in different SDS 
concentrations.
dynamic light scattering
Dynamic light scattering (DLS) is used to analyze the size distribution of 
suspended particles (54). In paper vI, DLS was used to analyze the size dis-
tribution of aggregates of C-peptide.
Infrared spectroscopy
Infrared (IR) spectroscopy gives details of molecular structure based on 
how the molecular bonds within a functional group can vibrate. In paper vI, 
attenuated total reflection (ATR) and Fourier transform (Ft) IR was used to 
study the secondary structure of oligomeric C-peptide.
nmr spectroscopy
The magnetic nuclear spin of certain atoms is a property that can be used to 
study structures, conformations and dynamics of molecules with NMR spec-
troscopy. In paper vI, diffusion NMR was used to study the size distribution 
of oligomeric C-peptide.
Thioflavine T staining
Thioflavine T is a dye that upon binding to aggregates of ß-sheet structure 
undergoes a characteristic transition in its emission spectrum (55).
cell bIology methods
cells and cell culture
In this thesis, HEK-293, Swiss-3T3, HCS-2/8 and proximal tubular cells have 
been used (papers I and III-Iv). HEK-293, or human embryonic kidney cells 
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from experiment nr 293, have been extensively used since the 70’s (56) for 
their ease to handle. The cell type is suggested to resemble immature neu-
rons (57). Swiss-3T3 cells originate from the 60’s (58) and are derived from 
primary mouse embryonic fibroblast cells. Fibroblasts are commonly found 
in connective tissue. HCS-2/8 cells have a cartilage phenotype and are used 
as a model system for chondrocytes in human cartilage. They are derived 
from a human chondrosarcoma (59). Proximal tubular cells are found in the 
nephrons of the kidneys, and were isolated from diabetic rats (60).
Cells at 50–80% confluency in passage 6-20 were used in all experiments, 
with the exception of chondrocytes that were used between passage 3-7. 
For experiments with live cells, cells were seeded in cold medium and serum 
starved for a minimum of 12 hrs prior to the experiment. This was performed 
to synchronize cells and to avoid disturbance arising from growth factors, 
hormones or other serum components.
Proximal tubular cells were not grown but only maintained in culture for 2 hrs.
cell viability analysis
The amount of cell death or proliferation reflects how a population of cells 
responds to external conditions. Analysis of viability was done as described 
in paper II.
dna microarray
DNA microarray is a technique allowing for large-scale transcription 
analysis, utilizing the intrinsic capacity of an mRNA molecule to bind to 
its precursor DNA sequence. Multiple, short DNA sequences from a gene 
are fused to a chip, and the binding of a complementary mRNA molecule 
results in a readable answer. In paper III, DNA microarray was used to 
study the effect of C-peptide on transcription of genes in renal tubular cells 
isolated from diabetic rats.
extraction of cellular material
For analysis of C-peptide and protein (papers I and Iv), RNA (paper II) and 
histone interactions (paper II), protein extraction methods were employed as 
described in each paper. Usually, for binding analysis a large extraction from 
one passage set was performed in order to minimize passage-to-passage 
variation.
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gene reporter assay
To screen for the transcription of a gene in the absence or presence of differ-
ent factors, it is valuable to do so in an intact cellular system. Reporter genes 
are constructs containing regulatory sequences of interest to the researcher, 
fused with a gene that upon expression results in a signal easy to identify 
and measure. These constructs are transfected into cells. In paper II, a 
luciferase construct was fused with an rDNA promoter sequence, and the 
emission of photons was monitored with a luminometer as a response to dif-
ferent experimental setups.
fluorescence-activated cell sorting 
Fluorescence-activated cell sorting (FACS) was used in papers I and II. The 
method relies on sorting cells based on their fluoresecent characteristics, as 
inferred to the cells by experimental procedures.
Immunofluorescence
The localization and abundance of molecules within a cell can be traced by 
their corresponding antibodies, and subsequently these antibodies are visual-
ized with fluorescent conjugates. This technique was used in papers I and II.
polymerase chain reaction analysis
Standard polymerase chain reaction (PCR) analysis has been used as 
described in papers II and III. For low-abundant genes, a relatively high 
number of cycles has been used.
statIstIcal methods
statistical analysis
Statistics deal with the numerical analysis of group- and population-sampled 
material, and serve to describe and infer properties of populations. In paper 
II, two-tailed paired student’s t-test and one-way analysis of variance were 
used to compare differences between populations. In paper III, Mann-Whit-
ney or Kruskal Wallis tests followed by Dunn’s post hoc test were used to 
compare differences between populations.
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results
paper I
cellular internalization of proinsulin c-peptide
We investigated whether C-peptide is actively internalized into cells. Using 
confocal microscopy imaging of immunostained and Rh-labeled C-peptide 
we showed that C-peptide is internalized, and that it also enters into the 
nucleus. Combining protein interaction and identification analysis with the 
Biacore technology and mass spectrometry, we also found that C-peptide 
interacts with intracellular proteins, including cytoskeletal proteins and a 
multi-domain kinase protein. 
paper II
proinsulin c-peptide regulates ribosomal rna expression 
With the finding of C-peptide being localized to the nucleus in paper I, we 
also observed that C-peptide accumulates in nuclear subcompartments. Co-
immunostaining revealed these compartments to be the rRNA-synthesizing 
nucleoli. C-peptide was found to rapidly induce transcription of rDNA, and 
to stimulate acetylation of and interact with histone 4 acetylated at lysine 16 
(acH4K16) at the rDNA promoter region. As rRNA synthesis is tightly coupled 
to proliferation, we investigated and observed that C-peptide stimulates 
proliferation in chondrocytes and HEK-293 cells. Based on these findings we 
suggest C-peptide to have cell-specific growth factor activity.
paper III
early transcriptional regulation by c-peptide in freshly 
isolated rat proximal tubular cells
The localization of C-peptide in nuclei and observed transcriptional effects 
showed in paper II made us want to investigate if there are any early-re-
sponse genes that C-peptide regulates. In type I diabetic patients, 
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C-peptide supplement has been shown to improve renal function. We iso-
lated proximal tubular cells from diabetic rats, incubated them with C-peptide 
for 2 hrs, and subsequently isolated mRNA that was analyzed with expres-
sion array genechips. ~500 genes were affected by C-peptide (p<0.01, fold 
change>1.3). Datamining of microarray data revealed that cardiovascular 
disease markers and diabetes complication markers are early reduced upon 
C-peptide stimulation.
paper Iv
proinsulin c-peptide interaction with protein tyrosine phosphatase 
1b demonstrated with a labeling reaction
To find novel interaction partners of C-peptide and hence understand more 
of C-peptide biological function, we explored a robust method to study 
interactions of this small and acidic peptide. A nickel-catalyzed crosslabeling 
reaction employing a small tag was modified to suit our requisite of a mass 
spectrometry-compatible workflow. A previous study had reported C-peptide 
to influence phosphatase activity in intact cells (61), and with our method we 
could demonstrate that C-peptide interacts with PTP1B. Specifically, labeling 
data combined with enzyme activity analysis showed a functional interaction 
between acidic regions of C-peptide resembling PTP1B binding substrates 
and specific sites of PTP1B.
paper v
oligomerization and insulin interactions of proinsulin c-peptide: 
threefold relationships to properties of insulin
Insulin exists as monomers and hexamers in equilibrium. A previous study 
(39) has shown that C-peptide interacts with and disaggregates insulin 
oligomers, increasing insulin bioavailability as monomers, which elicit the 
physiological response. We show that this relationship is also reciprocal: C-
peptide itself forms oligomers that are disaggregated by insulin. Thioflavine T 
staining shows C-peptide ß-sheet formation. 
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paper vI
structural features of proinsulin c-peptide oligomeric and amyloid 
states
In paper v, we showed the presence of C-peptide oligomers. In this study 
we made an effort to characterize the formation process and oligomer 
features by trapping low-abundant oligomers with SDS. We show that the 
C-peptide oligomers are sensitive to divalent ions and NaCl, implicating elec-
trostatic interactions involved in oligomer formation. We also show that the 
oligomers can form larger aggregates of ß-sheet structure, that SDS-induced 
oligomers are pH-sensitive, and that time is a contributing factor to oligomer 
formation. 
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dIscussIon 
In this thesis, findings are presented related to three topics; internalization 
of C-peptide and observations in connection to this (papers I-III), method de-
velopment to allow for identification of C-peptide interacting partners (paper 
Iv), and C-peptide oligomerization and properties thereof (papers v-vI). 
Below, the findings are discussed within these three sections followed by a 
more general discussion.
papers I-III
Intracellular c-peptide 
In papers I-III, the internalization of C-peptide and intracellular actions 
are described. In paper I, we show the internalization using two methods; 
confocal microscopy imaging of immunodetected and fluorescently labeled 
C-peptide (Rh-C-peptide), and FACS analysis. The methods evidence C-
peptide as an intracellular species, and Rh-C-peptide was observed also 
in the nucleus. The internalization was later corroborated by another group 
that showed the internalization to occur via endocytosis of clathrin-coated 
vesicles (62). Both our and their later study show that internalization begins 
already within 10 minutes, although Luppi et al. describe the localization of 
C-peptide to be punctuate, whereas we describe it as homogenous. There 
is no real size-difference between the probes used in each study, so the 
discrepancy between localization pattern can most likely be explained by the 
use of different cell types or their observation of C-peptide in endosomes. 
Luppi et al. observe no nuclear localization.
In paper I, four proteins are identified as intracellular C-peptide binding 
components. Three are cytoskeletal proteins, whereas calcium/calmodulin-
dependent serine protein kinase (CASK) is a multidomain scaffolding protein 
localized to the cytosol and nucleus (63). CASK contains a calcium/calmod-
ulin-dependent kinase (CaMK) module (64) that is known to be involved in 
cellular responses induced by hormones and other signaling agents. CaMK 
targets include transcription factor cyclic adenosine monophosphate (cAMP) 
response element-binding (CREB) protein, implicated in C-peptide signaling 
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(25). CREB is functionally related to activating transcription factors (ATF) 3 
and 4, that in paper III are shown to be affected by C-peptide. CASK also 
contributes to ion channel trafficking (65), which is interesting in the light of a 
study showing C-peptide ability to induce cation channels (35).
We suggested C-peptide to be an intracrine factor in paper I, and this report 
was recognized by others (66). How C-peptide and other intracrines traf-
fick from membranes and endosomes to nuclear and other compartments is 
unclear. Several other intracrines, including epidermal growth factor (EGF) 
and basic fibroblast growth factor (bFGF), have known membrane receptors 
with which they internalize, and release of peptide and receptor complexes 
in late endosomes can be mediated via the acidic milieu. Both EGF and 
bFGF appear in the nucleus, a pathway that for EGF requires internalization 
with its membrane receptor (67). EGF has also been found in a subpopula-
tion of endosomes that upon EGF stimulation are decorated with adaptor 
protein containing PH domain, PTB domain and leucine zipper motif (APPL) 
proteins, followed by membrane release and nuclear localization of APPL 
proteins (68). Whether this mediates the nuclear localization of EGF or just 
models a signal relay is unclear. Nonenveloped viruses that accumulate in 
endosomes via clathrin-coated vesicles have been shown to escape endo-
somes via unknown membrane interactions (69). Also signal transducer and 
activator of transcription 3 (STAT3) and c-Met accumulate in endosomes 
prior to nuclear localization (70). The trafficking of c-Met to perinuclear com-
partments has been shown to be under the control of PKC, which is also a 
target of C-peptide (28). An interesting mechanism proposed by Cook et al., 
suggests that trafficking of endosomes through the late recycling pathway 
to perinuclear recycling compartments allows for retrograde movement of 
nuclear targets through subcellular membrane pathways (71).
The trafficking from membranes and endosomes to the nucleus poses a 
mechanistic problem that remains to be answered not only for C-peptide 
and other intracrines. Other hormones, including steroids, have to escape 
endocytotic compartments as well to reach their intracellular target upon 
endocytosis (72).
The specific C-peptide nuclear localization evidenced in paper I led us to 
the observation in paper II that C-peptide accumulates in the nucleolus and 
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stimulates rDNA transcription. Insulin has also been reported to stimulate 
rDNA transcription (73), although no nucleolar localization has been ob-
served. Other intracrine factors such as bFGF and PTHrP also localize to the 
nucleolus, although PTHrP contains a nucleolar targeting sequence (74). 
The stimulation of rDNA transcription seems to be mediated via a complex 
situated at the 47S promoter. Interaction analysis revealed a binding be-
tween C-peptide and histone 4 (both non- and acetylated at K16). Analysis 
also showed an enrichment of acH4K16 at the promoter of 47S. C-peptide 
can induce acetylation of H4K16 within the time-frame of internalization, 
making it possible that C-peptide promotes this modification of H4K16 at the 
promoter. The acetylation of histone proteins is part of epigenetic mecha-
nisms involved in chromatin remodeling, but it is unclear if C-peptide causes 
an epigenetic change or whether it is a time-limited modification, as we see a 
decrease in rDNA transcription already after 8 hrs. 
C-peptide was also shown to interact with ribosomal protein S18. This is 
interesting not only because it provides an alternative verification of C-pep-
tide nucleolar localization, but also because ribosome assembly occurs in 
the nucleolus (75). To expand speculation further, S18 provides an interest-
ing link to both chemotaxis and CaMK-containing proteins such as CASK. 
C-peptide induces chemotaxis (76), and S18 interacts with cofilin (77), a 
protein involved in actin filament elongation (78). C-peptide has previously 
been shown to affect actin rearrangement (79) and in paper I binding to 
cytoskeletal proteins is observed. Although speculative, as reported in paper 
II and as evidenced in other studies, C-peptide does not physically interact 
with an abundance of proteins and those few that are interacting partners 
must be assumed to provide some insight into molecular function that can 
be pursued by experiments. S18 has also been shown to be a substrate for 
CaMK-proteins (80).
The increased transcription if 47S was further associated with proliferation in 
chondrocytes, a model system of interest in type I diabetes as ostopenia oc-
curs in these patients. Type I diabetic patients also suffer from slow healing 
rates of fractures (81), and it has been suggested that apoptosis of chondro-
cytes is involved in the impaired bone health (82). C-peptide is shown in pa-
per II to increase proliferation as well as to inhibit apoptosis in chondrocytes.
The nuclear localization and transcriptional activation of the rDNA gene by 
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C-peptide observed in paper II, made us profile gene transcription activities 
of C-peptide. C-peptide has previously been shown to affect transcription of 
vasopressin-activated Ca2+-mobilizing receptor (VACM-1) (83, 84) and eNOS 
(31), but as in the case of the VACM-1, long incubation times were used. The 
effect on eNOS expression was showed to occur via ERK pathway activa-
tion. Synergetic effects on transcription with other agents (79) and activation 
of the nuclear factor (NF) κB pathway via G-proteins (85) have also been 
observed. 
Our goal was to catch early regulated genes, prior to subsequent activa-
tion of signaling cascades, and we therefore incubated proximal tubular cells 
isolated from type I diabetic rats with C-peptide for 2 hrs. This incubation 
time was chosen on the basis of the observed internalization rate in paper I, 
where C-peptide was first observed in the nucleus after 20-30 min with com-
plete nuclear localization within 1 hr. We chose to study C-peptide effects in 
proximal tubular cells as one rapidly occurring effect of C-peptide in type I 
diabetic patients is normalization of glomerular hyperfiltration (86).
Analysis of mRNA from non-treated and treated samples with global gene 
expression profiling allowed us to observe which gene categories (87) that 
are predominantly activated. Categories related to transcriptional and GPCR 
activities were well represented, as were also catabolic enzymes, i.e. trans-
ferases. Of the ~500 genes affected by C-peptide, we chose ten candidates 
for real time quantitative (q) PCR analysis in order to validate the microarray 
analysis. The analysis confirmed activation of Gpr87 and Rup2 and repres-
sion of Atf3, whereas analysis of Atf4, Tfec and Map3k8 gave inconclusive 
results. The increased transcription of Ada, Mmp9, Tbx22 and Foxo3a 
opposed the results obtained using the Affymetrix platform. Several of the 
candidates chosen were low-expressed transcription factors, and only mate-
rial from one control rat remained for the qPCR analysis.
The use of different probes and amplification techniques causes correla-
tion problems when validating microarray results. Nevertheless, validation of 
candidates is important, in particular when identifying or pursuing a particular 
candidate of interest. In paper III, we focused on identifying overall trends 
and pathway association as this was the first microarray study to be conduct-
ed on C-peptide-stimulated samples.
The gene expression profiling allowed us to observe pathways that seem 
to be regulated by C-peptide, by employing different bioinformatic strategies 
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(88, 89). Most of the ~500 genes affected by C-peptide were repressed, sug-
gesting normalization of diabetes-induced malexpressed genes. This was 
confirmed by pathway analysis that implied correction of several disease 
markers and mechanisms including cardiovascular disease markers and 
diabetes complication markers. No disease biomarkers or genes involved in 
disease molecular mechanisms were increased by C-peptide.
In paper III, 27,000 genes were analyzed and less than 500 genes were 
significantly regulated by C-peptide, indicating that C-peptide exerts a tight 
transcriptional regulation and confirming that the time-frame of 2 hrs was ap-
propriately chosen.
paper Iv
c-peptide crosslabeling
In any quest of molecular function, a bottom-up approach can be to iden-
tify interacting molecules and deduce function from this approach rather 
than going via function to mediators. There are many protein interaction 
techniques, including IP, crosslinking, two-hybrid systems and others. As 
dicussed in the methodology section, many of these protein interaction tech-
niques are incompatible with the features of C-peptide. We tested a novel 
crosslabeling technique described in the literature by Brown et al. (51, 52), 
with compatible characteristics including a small tag. We used this technique 
to determine binding partners of C-peptide and found that our enzyme assay 
results showing C-peptide effects on PTP1B was in agreement with a physi-
cal interaction, even in more complex protein mixtures. We also used this 
technique to trap C-peptide oligomers (data not shown). 
This crosslabeling technique is of value when trying to confirm an inter-
action between known interactants, and the MS-compatible workflow we 
developed in this study gains the method sensitivity. If dealing with unknown 
interaction partners the technique is probably sensitive enough to catch the 
interaction, but the identification could pose a problem as that requires suf-
ficient amounts for analysis. The tag is sufficiently small to allow for intracel-
lular capture of interacting partners.
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papers v-vI
c-peptide oligomerization
When trying to corroborate C-peptide nuclear localization by Western blot 
analysis, no C-peptide band at 3 kDa was observed. A long troubleshoot-
ing period followed, experimenting with transfer times, buffers and finally 
even equipment. Invitrogen launched a rapid dry-blotting system with which 
we observed C-peptide using a nitrocellulose membrane. As we used pure 
C-peptide solutions, it was obvious to us that the four bands observed must 
all be C-peptide. We showed that these oligomers form with native as well 
as Rh-labeled and biotinylated C-peptide, and that the oligomeric interaction 
is relatively salt-insensitive and heat-insensitive (papers v-vI). Furthermore, 
the aggregates formed by oligomers are shown to be of ß-sheet structure, 
and we suggested in paper vI that C-peptide is amyloid-like. Other studies 
have found C-peptide deposits in vivo (76, 90). As data on fibril formation is 
lacking, it does not qualify as an amyloid peptide (91).
In a previous study, C-peptide had been observed to disrupt insulin oligom-
ers and to increase insulin bioavailability (39) but now we could show that 
insulin also disrupted C-peptide oligomers. This is interesting as Keltner 
et al. have shown that C-peptide is inactive by its ability to stimulate ATP 
release from erythrocytes prior to zinc binding (92). As insulin hexamers are 
stabilized by zinc and calcium (40), it is noteworthy that C-peptide upon insu-
lin hexamer disaggregation releases zinc which can activate C-peptide and 
calcium which can act as a C-peptide oligomer disruptive agent.
C-peptide acts both to facilitate proper folding of proinsulin and to release 
insulin monomers, ensuring hormone bioavailability in accordance with the free 
hormone transport hypothesis (93, 94). The latter could also be true in reverse, 
as data evidence C-peptide oligomer disruption by insulin as well. These 
actions well represent a chaperone-function of C-peptide, as deduced by 
Wojcikowski et al. (17), Chen et al. (95), Shafqat et al. (39) and us (paper v). 
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overall thoughts 
As the half-life of C-peptide far exceeds that of insulin (30 vs 5 min), it is 
reasonable to believe that C-peptide functions as a classical negative feed-
back loop molecule of insulin signaling pathways. This is supported by the 
fact that C-peptide inhibits insulin secretion (16), and also seems to regu-
late insulin bioavailability (39). However, there is also evidence of positive 
feedback loop mechanisms, as both C-peptide and insulin stimulate rDNA 
transcription via seemingly different mechanisms (96) (paper II), and insuli-
nomimetic effects have been described in the literature (25). That C-peptide 
and insulin in addition must exert completely different effects is evident on 
the basis of different appearances, both in regard of structural invariability 
and variability as well as basic chemical properties.
C-peptide exerts its activities in a compartmentalized fashion, extracellularly, 
at the cell surface and also intracellularly, Figure 5. To further specify these 
compartmentalized activities into tissue specific effects and to distinguish 
direct effects from secondary effects of C-peptide is a great challenge for 
future work. That a fine-tuned homeostasis of C-peptide is necessary for 
balanced effects is suggested by the long-term complications observed in 
type I diabetic patients. Evidence of long-term complications when reaching 
above normal physiological concentrations as in type II diabetes are also 
implicated. The sub- and supralevels of C-peptide observed in these dis-
eases most likely affects the body in many ways, although a major distinc-
A B C
Figure 5. Three-site activity model of C-peptide. (A) denotes C-peptide 
homo and C-peptide hetero interactions, (B) surface interactions with 
signaling cascade activation, and (C) intracellular and nuclear interactions.
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tion can be made. Sub-levels of C-peptide primarily seem to affect cellular 
function disturbing signaling pathways, whereas supra-levels are indicated to 
participate in aggregate formation. This remains to be further researched, as 
studies of C-peptide and type II diabetes primarily have involved measure-
ments of insulin levels.
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concludIng remarks 
Doing research on C-peptide has been a fascinating, educating, frustrating 
and creative journey. When I started I barely knew what C-peptide was, and 
today I find it difficult to leave this little peptide behind. Writing this thesis has 
given me the opportunity to observe new important stones still left unturned. 
I truly wish that C-peptide or an analogue will find a way into the clinic, and 
help patients suffering from type I diabetes complications.
If I were to commence on a graduate program on C-peptide function with the 
knowledge I have today, I would
 • investigate C-peptide at its site of synthesis, i.e. how it interacts with  
  different cell types in the Langerhans islets,
 • continue on methodological work to allow for detailed analysis of
  C-peptide interactions in the nucleus,
 • map C-peptide effects in one readily available model system to avoid  
  inference of cell type and signaling pathway accessibility,
 •  collaborate with clinicians and get my hands on as much data as
  possible when clinical trials of C-peptide supplementation are
  available.
Now this is not the end. It is not even the beginning of the end. But it is, 
perhaps, the end of the beginning.
Sir Winston Churchill
39
acknowledgements
hans Jörnvall – thanks for giving me freedom and support throughout the 
years. You are my Yoda: often hard to find, traveling to remote places – and 
always filled with wisdom. And somehow always there. Thank you.
 
bertrand Joseph – we made two le sexy papers. Thanks for always believ-
ing in my story, for your enthusiasm and for your lovely lab atmosphere – my 
second (lab)home away from (lab)home
 
Jawed shafqat – you are one of the nicest people I have ever met. Thanks 
for always being enthusiastic about my work, and encouraging wild ideas. I 
wished that you could have followed me all of the way.
 
And time for reflection with colleagues is for me a lifesaver; it is not 
just a nice thing to do if you have the time. It is the only way you can 
survive. (Margaret J. Wheatley)
Thanks to theres Jägerbrink for welcoming me to the lab, and being my 
roomie together with susanne vollmer and claudia staab, 
ylva kai-larsen, andreas cederlund, michael fitzen,
charlotte nerelius, protim sarker and frank nylén. Thanks to essam 
refai for always fixing things.
Special beer-tanks goes out to claudia, theres, ylva, susanne and 
andreas.
 
Thanks to invaluable collaborators for inspiration, new directions and fun – 
bertrand Joseph, ulrika nyman, lina nordquist, farasat Zaman, lars 
sävendahl, lena mäler, Jesper lind, patrick müller, karin dahlman-
wright, salah mahmoudi, boris eluteri and John wahren.
 
richard re, Julia cook and dana spence – thanks for sharing interesting 
views on C-peptide.
 
My predecessors mikael henriksson and ermias melles – thanks for 
paving the way, giving me lots of advice and putting up with all of my puppy 
questions.
40
 The ”lab-moms” monica lindh, marie ståhlberg, gunvor alvelius, ella 
cederlund, carina palmberg and margareta brandt – your technical ex-
pertise and practical help have been invaluable. And your lab-mom-ing. Yet 
another PhD has sailed through the lab.
 
A collective thanks to everyone else at chemistry 1 and MBB also contrib-
uting to the nice athmosphere both now and then: Ingegerd nylander, 
birgitta agerberth, Jan sjövall, Jan-olov höög, tomas bergman, an-
ders lundsjö, sam tryggvasson, sören lundmark, agneta nordberg, 
susanne rothstein, Åke rökaeus, linus Östberg, Juan astorga-wells, 
chad tunell, andreas almlen, maria tollin, gudmundur bergsson, 
uzma nazeeb, moin Ishrat, peter bergman, karl bodin, rannard sillard, 
mikko hellgren, Åke norberg, Johnny söderlund, Jan wiberg.
 
For the priceless support of nice company during coffee breaks, lunches 
and beers – carina peréz, helena skar, ulrika nyman, olle rengby, Sofi 
eriksson, carolina gustavsson, pascal dammeyer, Jesper ericsson, 
helin vakifahmetoglu-norberg and everyone that were there.
 
Thanks to my students elie el agha, anna holmlund, kristian hertzel – 
you taught me many things.
 
Many thanks to professors sven hovmöller, elke schweda, lena mäler, 
sophia hober and göran andersson for allowing me to participate in your 
research projects while I was an undergraduate.
 
Thanks to my high school teacher (math and physics) natan pass for saying 
”Don’t complicate things. Look at the information given and work with that.” It 
is still difficult for me. Because it is not easy.
 
Thanks to philip koeck for being such an excellent and open-minded gen-
eral chemistry teacher. First impressions do last, and that lasted a long way 
into undergraduate training for me.
 
Thanks to bengt bollmark for being a very encouraging lab teacher, and all 
other lab assistants that had patience with me during my undergraduate years.
41
Thanks to hakan for encouragement and inspiration during undergraduate 
training.
 
Thanks to eva severinsson, Stockholm Research School in Molecular Life 
Sciences and all of you who went with me!!!! That was so great.
 
Thanks to the inventor of my TENS machine! Writing is hard, but my neck is 
harder.
 
Thanks to all of my family and friends for being, well, simply being wonderful. 
You are many, and I give you many thanks and saluts. Special shout-outs to 
carina (my dancing queentita), helena (my roe deer), emma (from post-
lab-lattes to emmaemma), ullis (lab-friends-beers-mamas), carolina (keep 
dancing), anna (barcelona yes, see you more, yes!), emelie (always inspir-
ing and so you), maja (my very own fjällbäck), elisabeth (we go so way 
back it’s forward) and grandma moj. I hope to see more of you, and you, and 
you now!
 
mum and dad: I love your support and your eagerness to understand what 
I’m doing. Thanks for encouraging me.
 
Thanks to odd instances of strange coincidence.
 
Thanks to Karolinska Instititutet, the Swedish Research Council, the Wallen-
berg foundation and the Magnus Bergvall foundation for making this fantastic 
money-demanding venture possible.
 
Thanks to my boys, my loves, my stardust – Juan and astor. You make me 
want to have an early day, every day!
 
Stockholm, October 2010
Emma
 
I would maintain that thanks are the highest form of thought; and that 
gratitude is happiness doubled by wonder. 
G.K. Chesterton 
42
references
1. Steiner, D. F., Cunningham, D., Spigelman, L., and Aten, B. (1967)
 Insulin biosynthesis: evidence for a precursor, Science 157, 697-700.
2. Steiner, D. F., and Oyer, P. E. (1967) The biosynthesis of insulin and a  
 probable precursor of insulin by a human islet cell adenoma, Proc Natl  
 Acad Sci U S A 57, 473-480.
3. Steiner, D. F., and Clark, J. L. (1968) The spontaneous reoxidation of  
 reduced beef and rat proinsulins, Proc Natl Acad Sci U S A 60, 622-629.
4. Chan, S. J., Keim, P., and Steiner, D. F. (1976) Cell-free synthesis of rat  
 preproinsulins: characterization and partial amino acid sequence
 determination, Proc Natl Acad Sci U S A 73, 1964-1968.
5. Steiner, D. F. (1976) Editorial: Errors in insulin biosynthesis, N Engl J  
 Med 294, 952-953.
6. Budd, G. C., Pansky, B., and Glatzer, L. (1993) Preproinsulin mRNA in  
 the rat eye, Invest Ophthalmol Vis Sci 34, 463-469.
7. Brailoiu, E., Dun, S. L., Gao, X., Brailoiu, G. C., Li, J. G., Luo, J. J.,
 Yang, J., Chang, J. K., Liu-Chen, L. Y., and Dun, N. J. (2009) C-peptide
 of preproinsulin-like peptide 7: localization in the rat brain and activity in  
 vitro, Neuroscience 159, 492-500.
8. Kendzierski, K. S., Pansky, B., Budd, G. C., and Saffran, M. (2000)
 Evidence for biosynthesis of preproinsulin in gut of rat, Endocrine 13,  
 353-359.
9. (1972) Circulating proinsulin and the “C” peptide, Lancet 2, 748.
10. Horino, M., Kobayashi, K., and Suetsugu, N. (1973) A radioimmunoas- 
 say of porcine proinsulin C-peptide immunoreactivity, Endocrinol Jpn  
 20, 143-148.
11. Faber, O. K., Hagen, C., Binder, C., Markussen, J., Naithani, V. K., Blix,  
 P. M., Kuzuya, H., Horwitz, D. L., Rubenstein, A. H., and Rossing, N.  
 (1978) Kinetics of human connecting peptide in normal and diabetic   
 subjects, J Clin Invest 62, 197-203.
12. Zavaroni, I., Deferrari, G., Lugari, R., Bonora, E., Garibotto, G.,   
 Dall’Aglio, E., Robaudo, C., and Gnudi, A. (1987) Renal metabolism of  
 C-peptide in man, J Clin Endocrinol Metab 65, 494-498.
13. Kitabchi, A. E. (1977) Proinsulin and C-peptide: a review, Metabolism  
 26, 547-587.
43
14. Banting, F. G., and Best, C. H. (1922) The internal secretion of the 
 pancreas, Journal of Laboratory and Clinical Medicine 7, 251-266.
15. Dunbar, J. C., McLaughlin, W. J., Walsh, M. F., and Foa, P. P. (1976)  
 Insulin secretion and glucose uptake by isolated islets of the hamster.  
 Effect of insulin, proinsulin and C-peptide, Horm Metab Res 8, 1-6.
16. Toyota, T., Abe, K., Kudo, M., Kimura, K., and Goto, Y. (1975)
 Inhibitory effects of synthetic rat C-peptide 1 on insulin secretion in the  
 isolated perfused rat pancreas, Tohoku J Exp Med 117, 79-83.
17. Wojcikowski, C., Maier, V., Dominiak, K., Fussganger, R., and Pfeiffer,  
 E. F. (1983) Effects of synthetic rat C-peptide in normal and diabetic  
 rats, Diabetologia 25, 288-290.
18. Flatt, P. R., Swanston-Flatt, S. K., Hampton, S. M., Bailey, C. J., and  
 Marks, V. (1986) Specific binding of the C-peptide of proinsulin to
 cultured B-cells from a transplantable rat islet cell tumor, Biosci Rep 6,  
 193-199.
19. Zierath, J. R., Galuska, D., Johansson, B. L., and Wallberg-Henriksson,  
 H. (1991) Effect of human C-peptide on glucose transport in in vitro   
 incubated human skeletal muscle, Diabetologia 34, 899-901.
20. Johansson, B. L., Sjöberg, S., and Wahren, J. (1992) The influence of  
 human C-peptide on renal function and glucose utilization in type 1   
 (insulin-dependent) diabetic patients, Diabetologia 35, 121-128.
21. Bermudez, I., Beadle, D. J., Trifilieff, E., Luu, B., and Hietter, H. (1991)  
 Electrophysiological activity of the C-peptide of the Locusta insulin-
 related peptide. Effect on the membrane conductance of Locusta
 neurones in vitro, FEBS Lett 293, 137-141.
22. Zierath, J. R., Handberg, A., Tally, M., and Wallberg-Henriksson, H.   
 (1996) C-peptide stimulates glucose transport in isolated human
 skeletal muscle independent of insulin receptor and tyrosine kinase   
 activation, Diabetologia 39, 306-313.
23. Johansson, B. L., Linde, B., and Wahren, J. (1992) Effects of C-peptide  
 on blood flow, capillary diffusion capacity and glucose utilization in the  
 exercising forearm of type 1 (insulin-dependent) diabetic patients,
 Diabetologia 35, 1151-1158.
24. Wahren, J., Johansson, B. L., and Wallberg-Henriksson, H. (1994) Does  
 C-peptide have a physiological role?, Diabetologia 37 Suppl 2, S99-107.
25. Wahren, J., Ekberg, K., and Jörnvall, H. (2007) C-peptide is a bioactive  
44
 peptide, Diabetologia 50, 503-509.
26. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T.,
 Nygren, P., Ståhl, S., Ekberg, K., Johansson, B., Uhlen, S., Uhlen, M.,  
 Jörnvall, H., and Wahren, J. (1999) Specific binding of proinsulin C-pep- 
 tide to human cell membranes, Proc Natl Acad Sci U S A 96, 13318-  
 13323.
27. Ohtomo, Y., Aperia, A., Sahlgren, B., Johansson, B. L., and Wahren, J.  
 (1996) C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity  
 in synergism with neuropeptide Y, Diabetologia 39, 199-205.
28. Tsimaratos, M., Roger, F., Chabardes, D., Mordasini, D., Hasler,   
 U., Doucet, A., Martin, P. Y., and Feraille, E. (2003) C-peptide stimulates  
 Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending  
 limb, Diabetologia 46, 124-131.
29. Shafqat, J., Juntti-Berggren, L., Zhong, Z., Ekberg, K., Köhler, M.,
 Berggren, P. O., Johansson, J., Wahren, J., and Jörnvall, H. (2002
 Proinsulin C-peptide and its analogues induce intracellular Ca2+
 increases in human renal tubular cells, Cell Mol Life Sci 59, 1185-1189.
30. Forst, T., De La Tour, D. D., Kunt, T., Pfutzner, A., Goitom, K.,
 Pohlmann, T., Schneider, S., Johansson, B. L., Wahren, J., Lobig,   
 M., Engelbach, M., Beyer, J., and Vague, P. (2000) Effects of proinsulin
 C-peptide on nitric oxide, microvascular blood flow and erythrocyte   
 Na+,K+-ATPase activity in diabetes mellitus type I, Clin Sci (Lond) 98,  
 283-290.
31. Kitamura, T., Kimura, K., Makondo, K., Furuya, D. T., Suzuki, M.,
 Yoshida, T., and Saito, M. (2003) Proinsulin C-peptide increases nitric  
 oxide production by enhancing mitogen-activated protein-kinase-
 dependent transcription of endothelial nitric oxide synthase in aortic   
 endothelial cells of Wistar rats, Diabetologia 46, 1698-1705.
32. Henriksson, M., Pramanik, A., Shafqat, J., Zhong, Z., Tally, M., Ekberg,  
 K., Wahren, J., Rigler, R., Johansson, J., and Jörnvall, H. (2001)
 Specific binding of proinsulin C-peptide to intact and to detergent-
 solubilized human skin fibroblasts, Biochem Biophys Res Commun 280,  
 423-427.
33. Melien, O., Sandnes, D., Johansen, E. J., and Christoffersen, T. (2000)  
 Effects of pertussis toxin on extracellular signal-regulated kinase
 activation in hepatocytes by hormones and receptor-independent   
45
 agents: evidence suggesting a stimulatory role of G(i) proteins at a level  
 distal to receptor coupling, J Cell Physiol 184, 27-36.
34. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F.,  
 DiMarchi, R. D., Di Cera, E., and Williamson, J. R. (1997) Prevention of  
 vascular and neural dysfunction in diabetic rats by C-peptide, Science  
 277, 563-566.
35. Schlesinger, P., Ido, Y., and Williamson, J. (1998) Conductive channel  
 properties of human C-peptide incorporated  into planar lipid bilayers.,  
 Diabetes 47, A29.
36. Henriksson, M., Shafqat, J., Liepinsh, E., Tally, M., Wahren, J., Jörnvall,  
 H., and Johansson, J. (2000) Unordered structured of proinsulin 
 C-peptide in aqueous solution and in the presence of lipid vesicles, Cell  
 Mol Life Sci 57, 337-342.
37. Medawala, W., McCahill, P., Giebink, A., Meyer, J., Ku, C. J., and   
 Spence, D. M. (2009) A Molecular Level Understanding of Zinc 
 Activation of C-peptide and its Effects on Cellular Communication in the  
 Bloodstream, Rev Diabet Stud 6, 148-158.
38. Meyer, J. A., Froelich, J. M., Reid, G. E., Karunarathne, W. K., and   
 Spence, D. M. (2008) Metal-activated C-peptide facilitates glucose 
 clearance and the release of a nitric oxide stimulus via the GLUT1   
 transporter, Diabetologia 51, 175-182.
39. Shafqat, J., Melles, E., Sigmundsson, K., Johansson, B. L., Ekberg,   
 K., Alvelius, G., Henriksson, M., Johansson, J., Wahren, J., and 
 Jörnvall, H. (2006) Proinsulin C-peptide elicits disaggregation of 
 insulin resulting in enhanced physiological insulin effects, Cell Mol Life  
 Sci 63, 1805-1811.
40. Dunn, M. F. (2005) Zinc-ligand interactions modulate assembly and   
 stability of the insulin hexamer -- a review, Biometals 18, 295-303.
41. Henriksson, M., Nordling, E., Melles, E., Shafqat, J., Ståhlberg, M., 
 Ekberg, K., Persson, B., Bergman, T., Wahren, J., Johansson, J., and  
 Jörnvall, H. (2005) Separate functional features of proinsulin C-peptide,  
 Cell Mol Life Sci 62, 1772-1778.
42. Munte, C. E., Vilela, L., Kalbitzer, H. R., and Garratt, R. C. (2005)
 Solution structure of human proinsulin C-peptide, FEBS J 272,
 4284-4293.
46
43. Re, R., and Bryan, S. E. (1984) Functional intracellular renin-
 angiotensin systems may exist in multiple tissues, Clin Exp Hypertens A  
 6, 1739-1742.
44. Re, R. N. (2003) The intracrine hypothesis and intracellular peptide   
 hormone action, Bioessays 25, 401-409.
45. Re, R. N., and Cook, J. L. (2006) The intracrine hypothesis: an update,  
 Regul Pept 133, 1-9.
46. Bhatia, V., Saini, M. K., and Falzon, M. (2009) Nuclear PTHrP
 targeting regulates PTHrP secretion and enhances LoVo cell growth  
 and survival, Regul Pept 158, 149-155.
47. Laemmli, U. K. (1970) Cleavage of structural proteins during the
 assembly of the head of bacteriophage T4, Nature 227, 680-685.
48. Olert, J., Sawatzki, G., Kling, H., and Gebauer, J. (1979) Cytological  
 and histochemical studies on the mechanism of the selective silver   
 staining of nucleolus organizer regions (NORs), Histochemistry 60,
 91-99.
49. Tal, M., Silberstein, A., and Nusser, E. (1985) Why does Coomassie
 Brilliant Blue R interact differently with different proteins? A partial
 answer, J Biol Chem 260, 9976-9980.
50. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., and Whitehouse, C. M.  
 (1989) Electrospray ionization for mass spectrometry of large
 biomolecules, Science 246, 64-71.
51. Brown, K. C., Yang, S. H., and Kodadek, T. (1995) Highly specific
 oxidative cross-linking of proteins mediated by a nickel-peptide
 complex, Biochemistry 34, 4733-4739.
52. Amini, F., Kodadek, T., and Brown, K. C. (2002) Protein affinity labeling  
 mediated by genetically encoded peptide tags, Angew Chem Int Ed   
 Engl 41, 356-359.
53. Kelly, S. M., and Price, N. C. (2000) The use of circular dichroism in the  
 investigation of protein structure and function, Curr Protein Pept Sci 1,  
 349-384.
54. Schurr, J. M. (1977) Dynamic light scattering of biopolymers and
 biocolloids, CRC Crit Rev Biochem 4, 371-431.
55. LeVine, H., 3rd. (1993) Thioflavine T interaction with synthetic
 Alzheimer’s disease beta-amyloid peptides: detection of amyloid
 aggregation in solution, Protein Sci 2, 404-410.
47
56. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977)
 Characteristics of a human cell line transformed by DNA from human  
 adenovirus type 5, J Gen Virol 36, 59-74.
57. Shaw, G., Morse, S., Ararat, M., and Graham, F. L. (2002) Preferential  
 transformation of human neuronal cells by human adenoviruses and the  
 origin of HEK 293 cells, FASEB J 16, 869-871.
58. Todaro, G. J., and Green, H. (1963) Quantitative studies of the growth  
 of mouse embryo cells in culture and their development into established  
 lines, J Cell Biol 17, 299-313.
59. Takigawa, M., Tajima, K., Pan, H. O., Enomoto, M., Kinoshita, A.,
 Suzuki, F., Takano, Y., and Mori, Y. (1989) Establishment of a clonal   
 human chondrosarcoma cell line with cartilage phenotypes, Cancer Res  
 49, 3996-4002.
60. Palm, F., Cederberg, J., Hansell, P., Liss, P., and Carlsson, P. O. (2003)  
 Reactive oxygen species cause diabetes-induced decrease in renal   
 oxygen tension, Diabetologia 46, 1153-1160.
61. Li, Z. G., Qiang, X., Sima, A. A., and Grunberger, G. (2001) C-peptide  
 attenuates protein tyrosine phosphatase activity and enhances
 glycogen synthesis in L6 myoblasts, Biochem Biophys Res Commun  
 280, 615-619.
62. Luppi, P., Geng, X., Cifarelli, V., Drain, P., and Trucco, M. (2009)
 C-peptide is internalised in human endothelial and vascular smooth   
 muscle cells via early endosomes, Diabetologia 52, 2218-2228.
63. Gardner, K. L., Sanford, J. L., Mays, T. A., and Rafael-Fortney, J. A.
 (2006) CASK localizes to nuclei in developing skeletal muscle and   
 motor neuron culture models and is agrin-independent, J Cell Physiol  
 206, 196-202.
64. Mukherjee, K., Sharma, M., Urlaub, H., Bourenkov, G. P., Jahn, R.,
 Sudhof, T. C., and Wahl, M. C. (2008) CASK Functions as a Mg2+-
 independent neurexin kinase, Cell 133, 328-339.
65. Hsueh, Y. P. (2006) The role of the MAGUK protein CASK in neural   
 development and synaptic function, Curr Med Chem 13, 1915-1927.
66. Re, R. N., and Cook, J. L. (2007) Mechanisms of disease: Intracrine  
 physiology in the cardiovascular system, Nat Clin Pract Cardiovasc Med  
 4, 549-557.
48
67. Rakowicz-Szulczynska, E. M., Otwiaska, D., Rodeck, U., and
 Koprowski, H. (1989) Epidermal growth factor (EGF) and monoclonal  
 antibody to cell surface EGF receptor bind to the same chromatin
 receptor, Arch Biochem Biophys 268, 456-464.
68. Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A.,
 Uttenweiler-Joseph, S., Habermann, B., Wilm, M., Parton, R. G., and  
 Zerial, M. (2004) APPL proteins link Rab5 to nuclear signal transduction  
 via an endosomal compartment, Cell 116, 445-456.
69. Suikkanen, S., Antila, M., Jaatinen, A., Vihinen-Ranta, M., and Vuento,  
 M. (2003) Release of canine parvovirus from endocytic vesicles,
 Virology 316, 267-280.
70. Kermorgant, S., and Parker, P. J. (2008) Receptor trafficking controls  
 weak signal delivery: a strategy used by c-Met for STAT3 nuclear
 accumulation, J Cell Biol 182, 855-863.
71. Cook, J. L., and Re, R. (2009) Intracellular Accumulation and Nuclear  
 Trafficking of Angiotensin II and the Angiotensin II Type 1 Receptor, In  
 The Local Cardiac Renin-Angiotensin Aldosterone System (Frohlich, E.  
 D., Ed.).
72. Adams, J. S. (2005) “Bound” to work: the free hormone hypothesis   
 revisited, Cell 122, 647-649.
73. Antonetti, D. A., Kimball, S. R., Horetsky, R. L., and Jefferson, L. S.   
 (1993) Regulation of rDNA transcription by insulin in primary cultures of  
 rat hepatocytes, J Biol Chem 268, 25277-25284.
74. Henderson, J. E., Amizuka, N., Warshawsky, H., Biasotto, D., Lanske,  
 B. M., Goltzman, D., and Karaplis, A. C. (1995) Nucleolar localization  
 of parathyroid hormone-related peptide enhances survival of
 chondrocytes under conditions that promote apoptotic cell death,
 Mol Cell Biol 15, 4064-4075.
75. Fromont-Racine, M., Senger, B., Saveanu, C., and Fasiolo, F. (2003)  
 Ribosome assembly in eukaryotes, Gene 313, 17-42.
76. Walcher, D., Aleksic, M., Jerg, V., Hombach, V., Zieske, A., Homma,   
 S., Strong, J., and Marx, N. (2004) C-peptide induces chemotaxis of
 human CD4-positive cells: involvement of pertussis toxin-sensitive 
 G-proteins and phosphoinositide 3-kinase, Diabetes 53, 1664-1670.
49
77. Kusui, K., Sasaki, H., Adachi, R., Matsui, S., Yamamoto, K., Yamaguchi,  
 T., Kasahara, T., and Suzuki, K. (2004) Ribosomal protein S18 identified
 as a cofilin-binding protein by using phage display library, Mol Cell
 Biochem 262, 187-193.
78. Hitchcock-Degregori, S. E. (2006) Chemotaxis: Cofilin in the driver’s  
 seat, Curr Biol 16, R1030-1032.
79. Hills, C. E., Al-Rasheed, N., Willars, G. B., and Brunskill, N. J. (2009)  
 C-peptide reverses TGF-beta1-induced changes in renal proximal   
 tubular cells: implications for treatment of diabetic nephropathy, Am J  
 Physiol Renal Physiol 296, F614-621.
80. Mishra-Gorur, K., Singer, H. A., and Castellot, J. J., Jr. (2002) The S18  
 ribosomal protein is a putative substrate for Ca2+/calmodulin-activated  
 protein kinase II, J Biol Chem 277, 33537-33540.
81. Loder, R. T. (1988) The influence of diabetes mellitus on the healing of  
 closed fractures, Clin Orthop Relat Res, 210-216.
82. Kayal, R. A., Siqueira, M., Alblowi, J., McLean, J., Krothapalli, N., 
 Faibish, D., Einhorn, T. A., Gerstenfeld, L. C., and Graves, D. T. (2010)  
 TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during  
 fracture healing and stimulates chondrocyte apoptosis through FOXO1,  
 J Bone Miner Res 25, 1604-1615.
83. Luppi, P., Cifarelli, V., Tse, H., Piganelli, J., and Trucco, M. (2008)
 Human C-peptide antagonises high glucose-induced endothelial
 dysfunction through the nuclear factor-kappaB pathway, Diabetologia  
 51, 1534-1543.
84. Maestroni, A., Ruggieri, D., Dell’Antonio, G., Luzi, L., and Zerbini, G.  
 (2005) C-peptide increases the expression of vasopressin-activated
 calcium-mobilizing receptor gene through a G protein-dependent
 pathway, Eur J Endocrinol 152, 135-141.
85. Al-Rasheed, N. M., Willars, G. B., and Brunskill, N. J. (2006) C-peptide  
 signals via Galpha i to protect against TNF-alpha-mediated apoptosis of  
 opossum kidney proximal tubular cells, J Am Soc Nephrol 17, 986-995.
86. Johansson, B. L., Borg, K., Fernqvist-Forbes, E., Kernell, A., Odergren,  
 T., and Wahren, J. (2000) Beneficial effects of C-peptide on incipient
 nephropathy and neuropathy in patients with Type 1 diabetes mellitus,  
 Diabet Med 17, 181-189.
50
87. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry,  
 J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A.,
 Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C.,
 Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000)
 Gene ontology: tool for the unification of biology. The Gene Ontology  
 Consortium, Nat Genet 25, 25-29.
88. Hosack, D. A., Dennis, G., Jr., Sherman, B. T., Lane, H. C., and
 Lempicki, R. A. (2003) Identifying biological themes within lists of genes  
 with EASE, Genome Biol 4, R70.
89. Zubarev, R. A., Nielsen, M. L., Fung, E. M., Savitski, M. M.,
 Kel-Margoulis, O., Wingender, E., and Kel, A. (2008) Identification of  
 dominant signaling pathways from proteomics expression data,
 J Proteomics 71, 89-96.
90. Marx, N., Walcher, D., Raichle, C., Aleksic, M., Bach, H., Grub, M.,   
 Hombach, V., Libby, P., Zieske, A., Homma, S., and Strong, J. (2004)  
 C-peptide colocalizes with macrophages in early arteriosclerotic lesions  
 of diabetic subjects and induces monocyte chemotaxis in vitro,
 Arterioscler Thromb Vasc Biol 24, 540-545.
91. Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S.,
 Frangione, B., Ikeda, S., Masters, C. L., Merlini, G., Saraiva, M. J., and  
 Sipe, J. D. (2007) A primer of amyloid nomenclature, Amyloid 14,
 179-183.
92. Keltner, Z., Meyer, J. A., Johnson, E. M., Palumbo, A. M., Spence, D.  
 M., and Reid, G. E. (2010) Mass spectrometric characterization and   
 activity of zinc-activated proinsulin C-peptide and C-peptide mutants,  
 Analyst 135, 278-288.
93. Mendel, C. M. (1989) The free hormone hypothesis: a physiologically  
 based mathematical model, Endocr Rev 10, 232-274.
94. Mendel, C. M. (1992) The free hormone hypothesis. Distinction from the  
 free hormone transport hypothesis, J Androl 13, 107-116.
95. Chen, L. M., Yang, X. W., and Tang, J. G. (2002) Acidic residues on the  
 N-terminus of proinsulin C-Peptide are important for the folding of
 insulin precursor, J Biochem 131, 855-859.
96. Hannan, K. M., Rothblum, L. I., and Jefferson, L. S. (1998) Regulation  
 of ribosomal DNA transcription by insulin, Am J Physiol 275, C130-138.
